<PAGE> 1
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934
For the quarterly period ended June 30, 1998
[ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934
For the transition period from _______________ to ________________
Commission file number 0-24872
------------------------------
Physician Reliance Network, Inc.
------------------------------------------------------
(Exact Name of Registrant as Specified in Its Charter)
Texas 75-2495107
- ------------------------------------------------ -------------------
(State or Other Jurisdiction of Incorporation or (I.R.S. Employer
Organization) Identification No.)
5420 LBJ Freeway, Suite 900
Dallas, Texas 75240
- ---------------------------------------- ------------------
(Address of Principal Executive Offices) (Zip Code)
Registrant's Telephone Number, Including Area Code: (972) 392-8700
--------------
Indicate by check mark whether the registrant (1) has filed all
reports required to be filed by Section 13 or 15(d) of the Securities Exchange
Act of 1934 during the preceding 12 months (or for such shorter period that the
registrant was required to file such reports), and (2) has been subject to such
filing requirements for the past 90 days. Yes X No
--- ---
As of August 12, 1998, approximately 51,180,996 shares of Common Stock
were issued and outstanding.
<PAGE> 2
PART I - FINANCIAL INFORMATION
ITEM 1. FINANCIAL STATEMENTS.
The condensed consolidated financial statements include the accounts
of Physician Reliance Network, Inc. and its subsidiaries (collectively, the
"Company") and have been prepared by the Company, without audit, pursuant to
the rules and regulations of the Securities and Exchange Commission. Certain
information and footnote disclosures normally included in annual financial
statements prepared in accordance with generally accepted accounting principles
have been condensed or omitted pursuant to such rules and regulations. It is
suggested that these condensed consolidated financial statements be read in
conjunction with the audited consolidated financial statements and notes
thereto included in the Company's Annual Report on Form 10-K for the year ended
December 31, 1997, as filed with the Securities and Exchange Commission. In the
opinion of the Company, all adjustments necessary to present fairly the
information in the following consolidated financial statements of the Company
have been included. Please be advised that the results of operations for
interim periods are not indicative of the results of the full year.
2
<PAGE> 3
PHYSICIAN RELIANCE NETWORK INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
(IN THOUSANDS)
UNAUDITED
ASSETS
<TABLE>
<CAPTION>
June 30, December 31,
1998 1997
--------- ------------
<S> <C> <C>
Current assets:
Cash and cash equivalents $ 4,378 $ 2,772
Investment in common stock, net 3,042 2,301
Accounts receivable, net 98,105 87,160
Due from related parties 12,558 15,312
Other receivables 5,405 2,855
Inventories 12,200 8,078
Prepaid expenses and other 1,427 1,445
Income tax receivable 710 8,815
Deferred income tax 1,089 1,089
--------- ---------
Total current assets 138,914 129,827
--------- ---------
Property and equipment:
Land 15,260 15,240
Buildings 63,199 62,084
Furniture and equipment 129,597 121,363
Construction-in-progress 4,429 472
--------- ---------
212,485 199,159
Less- Accumulated depreciation (56,328) (46,676)
--------- ---------
Net property and equipment 156,157 152,483
--------- ---------
Investments 5,751 4,717
Service agreements, net 122,316 104,773
Excess of purchase price over the fair value of net
assets acquired, net 7,578 7,793
Other assets, net 1,264 1,041
--------- ---------
Total assets $ 431,980 $ 400,634
========= =========
</TABLE>
The accompanying notes are an integral part of these condensed
consolidated financial statements.
3
<PAGE> 4
PHYSICIAN RELIANCE NETWORK, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
(IN THOUSANDS EXCEPT PER SHARE AMOUNTS)
UNAUDITED
LIABILITIES AND STOCKHOLDERS' EQUITY
<TABLE>
<CAPTION>
June 30, December 31,
1998 1997
--------- ------------
<S> <C> <C>
Current liabilities:
Accounts payable $ 26,357 $ 24,380
Accrued liabilities
Salaries and benefits 7,813 7,969
Other 3,756 3,262
--------- ---------
11,569 11,231
Deferred revenue -- 1,904
Due to related party 3,856 4,908
Current maturities of long-term debt 10,418 8,683
Income tax payable 1,690 --
--------- ---------
Total current liabilities 53,890 51,106
Long-term debt, net of current maturities 46,293 42,386
Subordinated convertible promissory notes 900 7,275
Construction and retainage payable 402 275
Deferred income taxes 11,188 9,042
Minority interest 341 246
--------- ---------
Total liabilities 113,014 110,330
--------- ---------
Commitments and contingencies
Stockholders' equity:
Series A and B preferred stock, 10,000 shares
authorized, no shares issued and outstanding -- --
Series One Junior preferred stock, 500 shares
authorized, no shares issued and outstanding -- --
Common stock, no par value, $.01 stated value per
share, 150,000 shares authorized, 51,014 and 48,999
shares issued at June 30, 1998, and December 31,
1997, respectively 510 490
Additional paid-in capital 253,119 240,543
Common stock to be issued, 1,790 shares 21,183 19,885
Valuation adjustment - investment in common stock (258) (696)
Retained earnings 44,412 30,082
--------- ---------
Total stockholders' equity 318,966 290,304
========= =========
Total liabilities and stockholders' equity $ 431,980 $ 400,634
========= =========
</TABLE>
The accompanying notes are an integral part of these condensed
consolidated financial statements.
4
<PAGE> 5
PHYSICIAN RELIANCE NETWORK INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(IN THOUSANDS, EXCEPT PER SHARE AMOUNTS)
UNAUDITED
<TABLE>
<CAPTION>
Three Months Ended Six Months Ended
June 30, June 30,
--------------------- ---------------------
1998 1997 1998 1997
--------- --------- --------- ---------
<S> <C> <C> <C> <C>
Revenues:
Management fees $ 89,473 $ 66,899 $ 171,867 $ 134,465
Other revenues 7,821 5,815 15,940 11,022
--------- --------- --------- ---------
Total revenues 97,294 72,714 187,807 145,487
--------- --------- --------- ---------
Costs and expenses:
Salaries and benefits 23,033 20,504 45,020 40,227
Pharmaceuticals and supplies 36,006 23,212 67,811 46,962
General and administrative 15,058 15,885 30,088 27,898
Provision for uncollectible accounts 4,164 41,172 7,989 44,483
Depreciation and amortization 6,014 5,210 11,886 10,077
Interest expense 952 960 2,181 1,643
--------- --------- --------- ---------
Total costs and expenses 85,227 106,943 164,975 171,290
--------- --------- --------- ---------
Income (loss) before taxes 12,067 (34,229) 22,832 (25,803)
--------- --------- --------- ---------
Provision for income taxes:
Current 3,703 (12,323) 6,659 (9,394)
Deferred 752 477 1,843 876
--------- --------- --------- ---------
Total provision for income taxes 4,455 (11,846) 8,502 (8,518)
--------- --------- --------- ---------
Net income (loss) $ 7,612 $ (22,383) $ 14,330 $ (17,285)
========= ========= ========= =========
Net income (loss) per share
Basic $ 0.14 $ (0.44) $ 0.28 $ (0.34)
========= ========= ========= =========
Diluted $ 0.14 $ (0.44) $ 0.27 $ (0.34)
========= ========= ========= =========
Average number of shares outstanding
Basic 52,784 50,562 51,929 50,739
========= ========= ========= =========
Diluted 53,346 50,562 53,268 50,739
========= ========= ========= =========
</TABLE>
The accompanying notes are an integral part of these condensed
consolidated financial statements.
5
<PAGE> 6
PHYSICIAN RELIANCE NETWORK INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(IN THOUSANDS)
UNAUDITED
<TABLE>
<CAPTION>
Six Months Ended
June 30,
--------------------
1998 1997
-------- --------
<S> <C> <C>
Cash flows from operating activities:
Net income (loss) $ 14,330 $(17,285)
Adjustments to reconcile net income to net cash
used in operating activities
Depreciation and amortization 11,886 10,077
Undistributed earnings of investments (440) --
Deferred income tax, net 1,843 876
Amortization of deferred revenues (1,716) --
Provision for uncollectible accounts -- 44,483
Gain on sale of the ambulatory surgery center -- (511)
Changes in operating assets and liabilities:
Increase in receivables, net (10,945) (34,541)
Decrease (increase) in income tax receivable 8,105 (15,216)
Increase in inventories and prepaids (4,104) (2,275)
(Increase) decrease in other current assets (32) 340
Increase in accounts payable
and accrued liabilities 2,315 1,251
Increase in deferred liabilities -- 502
Decrease in due to related party (1,052) (1,770)
Increase in income tax payable 1,690 --
-------- --------
Net cash provided by (used in) operating activities 21,880 (14,069)
-------- --------
Cash flows from investing activities:
Capital expenditures (12,886) (20,470)
Construction and retainage 127 (265)
Service agreements (8,229) (5,603)
Capital contributions to limited partnership (461) --
Sale of the ambulatory surgery center -- 1,950
Other (651) --
-------- --------
Net cash used in investing activities (22,100) (24,388)
-------- --------
Cash flows from financing activities:
Net proceeds from borrowings under the Revolver 4,000 33,000
Payments on long-term borrowings (3,149) (1,761)
Issuance of common stock 975 190
-------- --------
Net cash provided by financing activities 1,826 31,429
-------- --------
Net increase (decrease) in cash and cash equivalents 1,606 (7,028)
Cash and cash equivalents, beginning of period 2,772 7,679
-------- --------
Cash and cash equivalents, end of period $ 4,378 $ 651
======== ========
</TABLE>
The accompanying notes are an integral part of these condensed
consolidated financial statements.
6
<PAGE> 7
PHYSICIAN RELIANCE NETWORK, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(IN THOUSANDS, EXCEPT PER SHARE AMOUNTS)
1. BASIS OF PRESENTATION:
The condensed consolidated financial statements include the accounts
of Physician Reliance Network, Inc. and its subsidiaries for the three months
and six months ended June 30, 1998, and 1997, respectively. All significant
intercompany transactions have been eliminated. Certain reclassifications of
prior year amounts have been made to conform to the current year presentation.
2. SUPPLEMENTAL CASH FLOW INFORMATION:
Supplemental schedule of noncash investing and financing activities
are as follows:
During the six months ended June 30, 1998, the Company acquired assets
in exchange for $6,916 of notes payable, assumption of liabilities of $236, and
has issued or agreed to issue approximately $4,421 of common stock in connection
with the execution of certain Service Agreements. On April 1, 1998, $8,500 of
the outstanding subordinated convertible promissory notes were converted to
common stock.
During the six months ended June 30, 1997, the Company acquired assets
in exchange for $10,309 of notes payable, $8,500 of subordinated convertible
promissory notes, and has issued or agreed to issue approximately $2,081 of
common stock in connection with the execution of certain Service Agreements.
<TABLE>
<CAPTION>
Six Months Ended June 30,
-------------------------
1998 1997
----------- -----------
<S> <C> <C>
Cash paid during the period:
Interest, net of amount capitalized $ 1,667 $ 1,232
Income taxes $ 750 $ 5,335
</TABLE>
3. MANAGEMENT FEES:
The following table summarizes the derivation of Management Fees for
the three and six months ended June 30, 1998.
<TABLE>
<CAPTION>
Three Months Ended June 30, Six Months Ended June 30,
--------------------------- -------------------------
1998 1997 1998 1997
--------- --------- --------- ---------
<S> <C> <C> <C> <C>
Medical practice revenues $ 118,122 $ 93,706 $ 229,611 $ 183,675
Amounts retained by physicians (28,649) (26,807) (57,744) (49,210)
--------- --------- --------- ---------
Management fees $ 89,473 $ 66,899 $ 171,867 $ 134,465
========= ========= ========= =========
</TABLE>
7
<PAGE> 8
4. EARNINGS PER SHARE:
The following is a reconciliation of the components of earnings per share
for the three and six months ended June 30, 1998 and 1997.
<TABLE>
<CAPTION>
Three Months Ended June 30, 1998 --
PER-SHARE
INCOME SHARES AMOUNT
--------- --------- ---------
<S> <C> <C> <C>
Basic earnings per share, June 30, 1998
Income available to common stockholders $ 7,612 52,784 $ 0.14
Effect of Dilutive Securities
Stock options -- 495 --
Subordinated convertible promissory notes 8 67 --
--------- --------- ---------
Diluted earnings per share, June 30, 1998 $ 7,620 53,346 $ 0.14
========= ========= =========
</TABLE>
<TABLE>
<CAPTION>
Three Months Ended June 30, 1997 --
PER-SHARE
INCOME SHARES AMOUNT
--------- --------- ---------
<S> <C> <C> <C>
Basic and diluted earnings per share,
June 30, 1998
Income available to common stockholders $(22,383) 50,562 $ (0.44)
========= ========= =========
</TABLE>
<TABLE>
<CAPTION>
Six Months Ended June 30, 1998 --
PER-SHARE
INCOME SHARES AMOUNT
--------- --------- ---------
<S> <C> <C> <C>
Basic earnings per share, June 30,1998
Income available to common stockholders $ 14,330 51,929 $ 0.28
Effect of dilutive securities
Stock options -- 479 0.01
Subordinated convertible promissory notes 144 860 --
--------- --------- ---------
Diluted earnings per share, June 30, 1997 $ 14,474 53,268 $ 0.27
======== ========= =========
</TABLE>
<TABLE>
<CAPTION>
Six Months Ended June 30, 1997 --
PER-SHARE
INCOME SHARES AMOUNT
--------- --------- ---------
<S> <C> <C> <C>
Basic and diluted earnings per share,
June 30, 1998
Income available to common stockholders $(17,285) 50,739 $ (0.34)
======== ========= =========
</TABLE>
Because the Company reported a loss for the three and six months ended
June 30, 1997, no additional securities or related adjustments to income
were made for the common stock equivalents related to stock options since the
effect would be antidilutive. If stock options had been included in the
computation of diluted earnings per share, the number of shares would have
increased by 350 and 298, for the three and six months ended June 30, 1997,
respectively.
8
<PAGE> 9
5. COMMITMENTS:
The service agreement with the Minnesota physician group provides for a
reduction of the Company's management fee under certain circumstances. For the
three and six months ended June 30, 1998, the Company's management fee was
reduced by $63 and $431, respectively.
6. STOCK BASED COMPENSATION:
Effective December 31, 1996, the Company adopted Statement of
Financial Accounting Standard ("SFAS") No. 123, "Accounting for Stock Based
Compensation;" however, the Company continues to account for stock based
compensation under Accounting Principles Board Opinion No. 25, "Accounting for
Stock Issued to Employees," as allowed by SFAS No. 123. Had compensation cost
for the Company's stock option plans been determined consistent with SFAS No.
123, the Company's net income and earnings per share would have been reduced to
the following pro forma amounts:
<TABLE>
<CAPTION>
Three Months Ended Six Months Ended
June 30, June 30,
------------------- -------------------
1998 1997 1998 1997
-------- -------- -------- --------
<S> <C> <C> <C> <C>
Net income (loss):
As reported $ 7,612 $(22,383) $ 14,330 $(17,285)
Pro forma $ 7,165 $(22,683) $ 13,384 $(17,982)
</TABLE>
Proforma basic earnings per share and diluted earnings per share would
have been as follows:
<TABLE>
<CAPTION>
Three Months Ended Six Months Ended
June 30, June 30,
------------------- -------------------
1998 1997 1998 1997
-------- -------- -------- --------
<S> <C> <C> <C> <C>
Basic earnings per share $ 0.14 $ (0.45) $ 0.26 $ (0.35)
Diluted earnings per share $ 0.13 $ (0.45) $ 0.25 $ (0.35)
</TABLE>
7. NEW ACCOUNTING STANDARDS:
In June 1997, the Financial Accounting Standards Board issued SFAS No.
130, "Reporting Comprehensive Income," which requires the presentation of total
nonowner changes in equity for all periods displayed. The Company holds shares
of common stock which are accounted for under SFAS No. 115 as
available-for-sale. The unrealized gains and losses on these securities are
treated as a component of comprehensive income under SFAS No. 130. The Company
has no other transactions that affect comprehensive income. The following is a
reconciliation of the Company's net income and comprehensive income for the
three and six months ended June 30, 1998, and 1997, respectively.
<TABLE>
<CAPTION>
Three Months Ended Six Months Ended
June 30, June 30,
------------------- -------------------
1998 1997 1998 1997
-------- -------- -------- --------
<S> <C> <C> <C> <C>
Net income (loss): $ 7,612 $(22,383) $ 14,330 $(17,285)
Unrealized gain (loss)on common (181) -- 438 --
stock, net of tax
-------- -------- -------- --------
Comprehensive income (loss) $ 7,431 $(22,383) $ 14,768 $(17,285)
======== ======== ======== ========
</TABLE>
9
<PAGE> 10
In June 1997, the Financial Accounting Standards Board issued SFAS No.
131, "Disclosures about Segments of an Enterprise and Related Information."
This standard defines reporting requirements for operating segments and related
information about products and services, geographic areas, and reliance on
major customers. The Company is evaluating the impact of this statement on its
current reporting and expects to adopt the new standard for its year ending
December 31, 1998.
8. SUBSEQUENT EVENT:
Effective July 1, 1998, the Company changed its amortization period of
current and future Service Agreements to 25 years on a prospective basis. This
change was made to be consistent with other companies in the Company's industry
which have made this change and to address opinions expressed by certain
financial regulatory bodies. Historically, the Company has amortized its Service
Agreements over the initial term of the agreements, which range from 30 to 40
years.
10
<PAGE> 11
ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND
RESULTS OF OPERATIONS
The following discussion of the results of operations and financial
condition of the Company should be read in conjunction with the Company's
Consolidated Financial Statements and Notes thereto included in its Annual
Report on Form 10-K for the year ended December 31, 1997, and with the
Condensed Consolidated Financial Statements included in this Form 10-Q.
OVERVIEW
The Company provides the management, facilities and equipment,
administrative and technical support, and other services necessary to establish
and maintain a fully-integrated network of outpatient oncology care. The
physician groups with whom the Company contracts ("Affiliated Physician
Groups") provide care related to the diagnosis and treatment of cancer on an
outpatient basis, including medical oncology, radiation oncology, gynecological
oncology, and diagnostic radiology. The Company earns its revenues for services
provided under its service agreements ("Service Agreements") with the
Affiliated Physician Groups. Under the Service Agreements, the Company receives
a management fee ("Management Fees") for services rendered, and the method of
determining the fee varies by each physician group.
The Company's most significant service agreement is with Texas
Oncology, P.A. ("TOPA", "Texas Service Agreement"). The Management Fee under
the Texas Service Agreement is calculated based upon a percentage of the
earnings before interest and taxes ("Earnings") plus nonphysician expenses of
the related practice locations. The Texas Service Agreement represented
approximately 71.1% and 72.7% of the Company's Management Fee revenue for the
three months and six months ended June 30, 1998, respectively, compared with
74.4% and 76.6% for the three and six months ended June 30, 1997, respectively.
Approximately 92% of the Company's Management Fees earned for both the three
and six months ended June 30, 1998, were derived from Service Agreements in
which the Management Fee is calculated based on Earnings and approximately 8%
were derived from Service Agreements in which the Management Fee is calculated
based on a fixed fee or a percentage of medical practice revenues.
The following table summarizes the derivation of Management Fees for
the three and six months ended June 30, 1998, and 1997 (in thousands)
<TABLE>
<CAPTION>
Three Months Ended Six Months Ended
June 30, June 30,
---------------------- ----------------------
1998 1997 1998 1997
--------- --------- --------- ---------
<S> <C> <C> <C> <C>
Medical practice revenues $118,122 $ 93,706 $229,611 $183,675
Amounts retained by physicians (28,649) (26,807) (57,744) (49,210)
--------- --------- --------- ---------
Management fees $ 89,473 $ 66,899 $171,867 $134,465
========= ========= ========= =========
</TABLE>
The following table sets forth the percentages of total revenues
represented by certain items reflected in the income statement. The information
that follows should be read in conjunction with the Condensed Consolidated
Financial Statements and Notes thereto included elsewhere herein.
11
<PAGE> 12
<TABLE>
<CAPTION>
Three Months Ended Six Months Ended
June 30, June 30,
------------------- ------------------
1998 1997 1998 1997
------- ------- ------- ------
<S> <C> <C> <C> <C>
Revenues:
Management fees 92.0% 92.0% 91.5% 92.4%
Other revenues 8.0 8.0 8.5 7.6
------- ------- ------- ------
Total revenues 100.0 100.0 100.0 100.0
Costs and expenses:
Salaries and benefits 23.6 28.2 24.0 27.7
Pharmaceutical and supplies 37.0 31.9 36.1 32.3
General and administrative 15.5 21.8 16.0 19.2
Provision for uncollectible accounts 4.3 56.7 4.3 30.6
Depreciation and amortization 6.2 7.2 6.3 6.9
------- ------- ------- ------
Income before interest expense and taxes 13.4 (45.8) 13.3 (16.7)
Interest expense 1.0 1.3 1.1 1.1
------- ------- ------- ------
Income before income taxes 12.4 (47.1) 12.2 (17.8)
Income taxes 4.6 (16.3) 4.6 (5.9)
------- ------- ------- ------
Net income 7.8% (30.8)% 7.6% (11.9)%
======= ======= ======= ======
</TABLE>
THREE MONTHS ENDED JUNE 30, 1998, COMPARED TO THE THREE MONTHS ENDED
JUNE 30, 1997
MANAGEMENT FEES. Management Fees were $89,473,000 for the three months
ended June 30, 1998, compared to $66,899,000 for the three months ended
June 30, 1997, representing an increase of $22,574,000 or 33.7%. The growth in
Management Fees is attributable to a $24,416,000 increase in Medical Practice
Revenues generated by the Affiliated Physician Groups offset by an increase in
Amounts Retained by Physicians pursuant to the Service Agreements of
$1,842,000. The growth in Medical Practice Revenues during the three months
ended June 30, 1998, is attributable to an increase in the number of physicians
by 21 from 319 to 340; an increase in the number of service locations from 111
to 127; and expansion of services provided at existing locations.
In April 1997, the Company assumed the operations of an existing
radiation facility in Columbia, Missouri, and in March 1998, these operations
were moved to an existing Company location where construction was completed to
integrate the medical and radiation oncology services. The Company also assumed
operations of existing radiation therapy facilities in Eugene, Oregon in
June 1997 and Beaumont, Texas in November 1997 through a joint venture with a
hospital in those markets. In January 1998, the Company assumed the operations
of an existing full-service cancer center in Chicago, Illinois in connection
with the execution of a new Service Agreement with a physician group. In June
1998, the Company opened a full-service cancer center in Denison, Texas.
Amounts Retained by Physicians were 29.4% of total revenues for the
three months ended June 30, 1998, compared to 36.9% of Medical Practice Revenues
for the comparable period in 1997. The decrease in the percentage is primarily
due to additional revenues earned from the Company's retail pharmacy operations
and investment in common stock which are not shared with the Affiliated
Physician Groups pursuant to the Service Agreements. See "Other Revenues."
Medical Practice Revenues, used in part to determine the Company's
Management Fees, derived from payors who have contracted with the Affiliated
Physician Groups to provide services on a discounted fee-for-service basis
accounted for approximately 45% of the Affiliated Physician Groups' business
during 1998. Approximately 35% of the Medical Practice Revenues generated by
the Affiliated Physician Groups during 1998, were from government agencies,
primarily Medicare and Medicaid.
12
<PAGE> 13
OTHER REVENUES. Other revenues for the three months ended June 30,
1998, were $7,821,000 compared to $5,815,000 for the three months ended June
30, 1997, representing an increase of $2,006,000, or 34.5%. Other revenues are
primarily derived from retail pharmacy operations located in certain of the
Company's cancer centers and larger physician offices, research activities
performed by the Company's affiliated physicians that are sponsored by
pharmaceutical companies, and the Company's interest in Ilex(TM) Oncology, Inc.
("ILEX"). Other revenues increased as a result of the development and expansion
of the Company's retail pharmacy and research lines of business. Other revenues
also increased $858,000 as a result of the receipt of ILEX common stock in
connection with the execution of a service agreement with ILEX in June 1997.
SALARIES AND BENEFITS. Salaries and benefits for the three months
ended June 30, 1998, were $23,033,000 compared to $20,504,000 for the three
months ended June 30, 1997, representing an increase of $2,529,000 or 12.3%.
Salaries and benefits include costs of nonphysician clinical employees of
Affiliated Physician Groups paid by the Company pursuant to the terms of the
Service Agreements. The dollar increase in the salaries and benefits was due to
the addition of clinical and nonclinical personnel required to support the
increase in the number of Affiliated Physician Groups managed by the Company
offset, in part, by reductions of personnel through the restructuring of
corporate and field office operations. The percentage of salaries and benefits
to total revenues was 23.6% for the three months ended June 30, 1998, compared
to 28.2% for the comparable period in 1997. This decrease is attributable to
the streamlining of both clinical and corporate operations, restructuring of
the Company's benefits program provided to employees, and increases in Medical
Practice Revenues and Other Revenues where the increased revenues were greater
than the incremental increase in salary and benefits.
PHARMACEUTICALS AND SUPPLIES. Pharmaceuticals and supplies for the
three months ended June 30, 1998, were $36,006,000 compared to $23,212,000 for
the three months ended June 30, 1997, representing an increase of $12,794,000
or 55.1%. The percentage of pharmacy and supplies to total revenues was 37.0%
for the three months ended June 30, 1998, compared to 31.9% for the three
months ended June 30, 1997. Both the dollar and percentage increases in
pharmaceuticals and supplies is primarily attributable to an increase in
infusion services generated by the Affiliated Physician Groups, both through
the increased number of physicians managed by the Company and the enhancement
of services provided in physician offices, cancer centers, and retail
pharmacies.
GENERAL AND ADMINISTRATIVE. General and administrative expenses for the
three months ended June 30, 1998, were $15,058,000 compared to $15,885,000 for
the three months ended June 30, 1997, representing a decrease of $827,000 or
5.2%. The percentage of general and administrative expenses to total revenues
was 15.5% for the three months ended June 30, 1998, compared to 21.8% for the
three months ended June 30, 1997. For the three months ended June 30, 1997, a
$3,133,000 nonrecurring charge was recorded for costs for legal and other
expenses related to pending shareholder and other litigation and the write-off
of certain deferred costs. After considering the nonrecurring charge recorded in
1997, general and administrative expenses increased $2,306,000. The increase in
general and administrative resulted from increased lease costs, utilities,
property taxes, telecommunications, and postage to support the Company's
additional service locations and expanded operations at existing locations and
increased maintenance costs on the Company's existing radiation and diagnostic
imaging equipment located in its cancer and diagnostic radiology centers.
PROVISION FOR UNCOLLECTIBLE ACCOUNTS. The provision for uncollectible
accounts for the three months ended June 30, 1998, was $4,164,000 compared to
$41,172,000 for the three months ended June 30, 1997, representing a decrease
of $37,008,000. For the quarter ended June 30, 1997, the Company provided
approximately $37,841,000 in additional provision for uncollectible accounts
receivable outstanding at June 30, 1997. The additional provision was for
accounts receivable that the Company deemed to be uncollectible as a result of
an extensive review of its outstanding accounts receivable and collection
experience utilizing reports and analyses not previously available to the
Company.
13
<PAGE> 14
DEPRECIATION AND AMORTIZATION. Depreciation and amortization for the
three months ended June 30, 1998, was $6,014,000 compared to $5,210,000 for the
three months ended June 30, 1997, representing an increase of $804,000 or
15.4%. Depreciation increased $606,000 as a result of the additional office and
cancer center locations that were opened by the Company since June 30, 1997.
Amortization increased $198,000 as a result of the increase in costs incurred
by the Company for physician groups entering into new Service Agreements.
INTEREST. Interest expense for the three months ended June 30, 1998,
was $952,000 compared to $960,000 for the three months ended June 30, 1997,
representing a decrease of $8,000 or 0.8%. Interest expense arises as a result
of borrowings under the Company's revolving credit facility (the "Revolver")
and amounts owed to Affiliated Physician Groups as consideration, in part, for
entering into Service Agreements.
INCOME TAXES. The income tax provision was $4,455,000 for the three
months ended June 30, 1998, compared to an income tax benefit of $11,846,000
for the three months ended June 30, 1997, representing an increase of
$16,301,000. The Company is carrying forward a tax loss that it incurred during
the year ended December 31, 1997, to future year income tax returns and
offsetting the loss with taxable income. Income taxes were provided on the
taxable income of the Company for federal and state reporting purposes using
the applicable effective rates except that the additional provision for
uncollectible accounts recorded in 1997 was provided at the applicable federal
rate.
SIX MONTHS ENDED JUNE 30, 1998, COMPARED TO THE SIX MONTHS ENDED JUNE 30, 1997
MANAGEMENT FEES. Management Fees were $171,867,000 for the six months
ended June 30, 1998, compared to $134,465,000 for the six months ended June 30,
1997, representing an increase of $37,402,000 or 27.8%. The growth in
Management Fees is attributable to a $45,936,000 increase in Medical Practice
Revenues generated by the Affiliated Physician Groups offset by an increase in
Amounts Retained by Physicians pursuant to the Service Agreements of
$8,534,000. The growth in Medical Practice Revenues during the six months ended
June 30, 1998, is due to an increase in the number of physicians by 21 from 319
to 340; an increase in the number of service locations from 111 to 127; and
growth of the revenue base from expansion of services provided at existing
locations.
Amounts Retained by Physicians were 30.7% of total revenues for the
six months ended June 30, 1998, compared to 33.8% of total revenues for the
comparable period in 1997. The decrease in the percentage is primarily due to
additional revenues earned from the Company's retail pharmacy operations and
investment in common stock which are not shared with the Affiliated Physician
Groups pursuant to the Service Agreements. See "Other Revenues."
Medical Practice Revenues, used in part to determine the Company's
Management Fees, derived from payors who have contracted with the Affiliated
Physician Groups to provide services on a discounted fee-for-service basis
accounted for approximately 45% of the Affiliated Physician Groups' business
during 1998. Approximately 35% of the Medical Practice Revenues generated by the
Affiliated Physician Groups during June 30, 1998, were from government agencies,
primarily Medicare and Medicaid.
OTHER REVENUES. Other revenues for the six months ended June 30, 1998,
were $15,940,000 compared to $11,022,000 for the six months ended June 30,
1997, representing an increase of $4,918,000, or 44.6%. Other revenues are
primarily derived from retail pharmacy operations located in certain of the
Company's cancer centers and larger physician offices, research activities
performed by the Affiliated Physician Groups that are sponsored by
pharmaceutical companies, and the Company's equity interest in ILEX. The
increase in other revenues was primarily attributable to the development and
expansion of the Company's retail pharmacy and research lines of business.
Other revenues also increased $1,662,000 as a result of the receipt of ILEX
common stock in connection with the execution of a service agreement with ILEX
in June 1997. Other revenues for the six months ended June 30, 1997, includes a
$511,000 gain on the sale of the Company's interest in an ambulatory surgery
center.
14
<PAGE> 15
SALARIES AND BENEFITS. Salaries and benefits for the six months ended
June 30, 1998, were $45,020,000 compared to $40,227,000 for the six months
ended June 30, 1997, representing an increase of $4,793,000 or 11.9%. Salaries
and benefits include costs of clinical nonphysician personnel of Affiliated
Physician Groups managed by the Company. The dollar increase in the salaries
and benefits was due to the addition of clinical and nonclinical personnel
required to support the increase in the number of Affiliated Physician Groups
managed by the Company offset, in part, by reductions of personnel through the
restructuring of corporate and field office operations. The percentage of
salaries and benefits to total revenues was 24.0% for the six months ended June
30, 1998, compared to 27.7% for the comparable period in 1997. This decrease is
attributable to the streamlining of both clinical and corporate operations,
restructuring of the Company's benefits program provided to employees, and
increases in Medical Practice Revenues and Other Revenues where the increased
revenues were greater than the incremental increase in salary and benefits.
PHARMACEUTICALS AND SUPPLIES. Pharmaceuticals and supplies for the six
months ended June 30, 1998, were $67,811,000 compared to $46,962,000 for the
six months ended June 30, 1997, representing an increase of $20,849,000 or
44.4%. The percentage of pharmacy and supplies to total revenues was 36.1% for
the six months ended June 30, 1998, compared to 32.3% for the six months ended
June 30, 1997. Both the dollar and percentage increases in pharmaceutical and
supplies is primarily attributable to an increase in infusion services
generated by the Affiliated Physician Groups, both through the increased number
of physicians and the enhancement of services provided in physician offices,
cancer centers, and retail pharmacies.
GENERAL AND ADMINISTRATIVE. General and administrative expenses for
the six months ended June 30, 1998, were $30,088,000 compared to $27,898,000
for the six months ended June 30, 1997, representing an increase of $2,190,000
or 7.9%. The percentage of general and administrative expenses to total
revenues was 16.0% for the six months ended June 30, 1998, compared to 19.2%
for the six months ended June 30, 1997. For the six months ended June 30, 1997,
a $3,133,000 nonrecurring charge was recorded for costs for legal and other
expenses related to pending shareholder and other litigation and the write-off
of certain deferred costs. After considering the nonrecurring charge recorded
in 1997, general and administrative expenses increased $5,323,000. The increase
in general and administrative resulted from increased lease costs, utilities,
property taxes, telecommunications, and postage to support the Company's
additional service locations and expanded operations at existing locations and
increased maintenance costs on the Company's existing radiation and diagnostic
imaging equipment located in its cancer and diagnostic radiology centers.
PROVISION FOR UNCOLLECTIBLE ACCOUNTS. The provision for uncollectible
accounts for the six months ended June 30, 1998, was $7,989,000 compared to
$44,483,000 for the six months ended June 30, 1997, representing a decrease of
$36,494,000. For the quarter ended June 30, 1997, the Company provided
approximately $37,841,000 in additional provision for uncollectible accounts
receivable outstanding at June 30, 1997. The additional provision was for
accounts receivable that the Company deemed uncollectible as a result of an
extensive review of its outstanding accounts receivable and collection
experience utilizing reports and analyses not previously available to the
Company.
DEPRECIATION AND AMORTIZATION. Depreciation and amortization for the
six months ended June 30, 1998, was $11,886,000 compared to $10,077,000 for the
six months ended June 30, 1997, representing an increase of $1,809,000 or
18.0%. Depreciation increased $1,433,000 as a result of the additional office
and cancer center locations that were opened or assumed by the Company since
June 30, 1997. Amortization increased $376,000 as a result of the increase in
costs incurred by the Company for physician groups entering into new Service
Agreements.
INTEREST. Interest expense for the six months ended June 30, 1998, was
$2,181,000 compared to $1,643,000 for the six months ended June 30, 1997,
representing an increase of $538,000 or 32.7%. Interest expense arises as a
result of borrowings under the Company's revolving credit facility and amounts
owed to Affiliated Physician Groups as consideration, in part, for entering
into Service Agreements.
INCOME TAXES. The income tax provision was $8,502,000 for the six
months ended June 30, 1998, compared to an income tax benefit of $8,518,000 for
the six months ended June 30, 1997. The Company is carrying forward a tax loss
that it incurred during the year ended December 31, 1997, to future year income
tax returns and
15
<PAGE> 16
offsetting the loss with taxable income. Income taxes were provided on the
taxable income of the Company for federal and state reporting purposes using
the applicable effective rates except that the additional provision for
uncollectible accounts recorded in 1997 was provided at the applicable federal
rate.
LIQUIDITY AND CAPITAL RESOURCES
The Company has historically generated its cash flows from operations,
bank financing, and the sale of securities. The Company's primary cash
requirements are for construction of cancer centers, acquisition of equipment
for cancer centers and medical offices, financing receivables, and acquiring
assets from and entering into Service Agreements with Affiliated Physician
Groups.
Net cash provided by operations for the six months ended June 30,
1998, was $21,880,000. Collections of the Company's accounts receivable are an
integral part of the Company's liquidity from operating activities. Under the
terms of most of the Company's Service Agreements, the Company purchases from
the Affiliated Physician Groups the accounts receivable arising from Medical
Practice Revenues at their estimated fair value at the end of each month. Net
cash provided by operations decreased $10,945,000 as a result of the increase
in outstanding accounts receivable. The increase in accounts receivable is
attributable to the increase in Medical Practice Revenues since December 31,
1997. Net cash provided by operations increased $8,105,000 as a result of the
reduction in the income tax receivable. In March 1998, the Company received a
$3,850,000 refund on income taxes that were paid in 1997, prior to a writedown
of its accounts receivable and other nonrecurring expenses that were incurred
during 1997. This writedown resulted in a tax loss for the year ended December
31, 1997, which is being carried forward to offset taxable income for 1998 and
to reduce the related income tax receivable. The Company has advanced to its
Affiliated Physician Groups, primarily TOPA, amounts needed for working capital
purposes primarily to assist with the development of new markets. The advances
decreased $2,754,000 since December 31, 1997, to $12,558,000. These advances
bear interest at the prime rate (8.5% at June 30, 1998).
Net cash used in investing activities for the six months ended June
30, 1998, was $22,100,000. During the six months ended June 30, 1998, the
Company expended $8,229,000 in partial consideration to enter into Service
Agreements. Capital expenditures during the six months ended June 30, 1998,
were $12,886,000. The Company continued and completed the construction of
cancer centers in Columbia, Missouri and Denison, Texas. Construction of a
cancer center in Maplewood, Minnesota continued and was completed in July 1998.
These expenditures were funded through cash flow provided by operations and
through borrowings under the Revolver. Contributions to a limited partnership
were $461. The limited partnership, in which the Company is the general
partner, continued and completed construction of a cancer center in Eugene,
Oregon.
Net cash flows from financing activities for the six months ended June
30, 1998, were $1,826,000. At June 30, 1998, borrowings under the Revolver were
$36,000,000, an increase of $4,000,000 since December 31, 1997. Payments to
Affiliated Physician Groups on long-term notes issued as partial consideration
for entering into Service Agreements were $3,149,000.
The Revolver provides for maximum borrowings of $140,000,000. The
Company has the option of financing borrowings under the Revolver at either a
LIBOR-based rate (LIBOR plus .90% at June 30, 1998) or at Bank One Texas,
N.A.'s prime rate (8.5% at June 30, 1998). The Revolver contains covenants
that, among other things, require the Company to maintain certain financial
ratios and impose restrictions on the Company's ability to pay cash dividends,
sell assets, and redeem or repurchase the Company's securities. At June 30,
1998, $104,000,000 was available for borrowing under the Revolver.
The Company expects that its principal use of funds in the foreseeable
future will be for the construction of cancer centers and the acquisition of
related equipment; the acquisition of medical practice assets; payments to
Affiliated Physician Groups as consideration for entering into Service
Agreements; repayment of notes issued in connection with the acquisition of
Service Agreements; debt repayments under the Revolver; and working capital. The
Company believes that cash flows provided by operations and the unused borrowing
capacity under
16
<PAGE> 17
the Revolver will be sufficient to meet its needs, and, therefore, the Company
does not anticipate raising capital through offerings of common stock to the
public in the near-term. The Company believes it has adequate access to other
forms of financing at reasonable terms to meet the capital requirements of its
construction and network development programs through 1999, including but not
limited to increasing the amount available for borrowing under the Revolver.
However, no assurance exists that such additional financing will be available in
the future or that, if available, it will be available on terms acceptable to
the Company.
YEAR 2000 COMPLIANCE
The Company is dependent upon its computer systems to bill patients for
services rendered by the Affiliated Physician Groups and to accumulate and
report the related revenues and expenses of Affiliated Physician Groups. The
Company's principal patient accounting system is not currently capable of
processing year 2000 transactions; however, the vendor is expected to deliver an
update to the software during the third quarter of 1998 to make the system
operational for the year 2000. The Company does not believe that the costs to
make the current practice management systems and other ancillary computer
systems operational for the year 2000 will be material. In addition, the Company
is currently installing a new general ledger, materials management, and accounts
payable system that is year 2000 compatible. This new financial system is
expected to be fully installed and operational by the third quarter of 1998. The
Company is also currently assessing a new practice management system that is
year 2000 compatible, and the installation is expected to be fully installed and
operational before January 2000. The total cost of the new practice management
system, exclusive of internal costs, is anticipated to be between $4-5 million.
Such costs will be funded through operations or working capital advances under
the Revolver. A committee has also been formed to address the Year 2000
implications throughout the Company, particularly as it relates to its medical
equipment used in its cancer centers and office locations. The Company does not
anticipate that material costs will be incurred to make equipment affected by
the Year 2000 operational.
17
<PAGE> 18
PART II - OTHER INFORMATION
ITEM 1. LEGAL PROCEEDINGS.
Inapplicable.
ITEM 2. CHANGES IN SECURITIES.
Except as described below in response to this item, no securities of
the Company have been sold by the Company during the three-month period ended
June 30, 1998, without registration under the Securities Act of 1933. The
issuance of securities described below have been, or will be, made in reliance
on Section 4(2) of the Securities Act of 1933.
Effective April 1, 1998, the Company entered into a Purchase Agreement
with Israel Wiznitzer, M.D. ("Wiznitzer") and agreed to issue Wiznitzer, as
partial consideration for the assets purchased and for affiliating with
Hematology Oncology Associates of Illinois, L.L.C. ("HOA"), one of the Company's
Affiliated Physician Groups, shares of Common Stock having an aggregate value of
$256,500 to be issued on April 1, 2002.
Effective April 1, 1998, the Company entered into a Purchase Agreement
with Max Haid, M.D. ("Haid") and agreed to issue Haid, as partial consideration
for the assets purchased and for affiliating with HOA shares of Common Stock
having an aggregate value of $313,500 to be issued on April 1, 2002.
Effective April 1, 1998, the Company issued 5,032 shares to HOA
pursuant to the terms of a Regional Consulting Agreement between the Company and
HOA.
Effective May 1, 1998, the Company agreed to issue to Mid-Missouri
Radiation Consultants, Inc. 20,064 shares of Common Stock pursuant to the terms
of a Regional Consulting Agreement, of which 5,016 shares were issued on May 1,
1998, and 5,016 shares will be issued on each of October 1, 1998, 1999, and
2000.
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURE ABOUT MARKET RISK.
Inapplicable.
ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS.
The Company held its Annual Meeting of Shareholders on May 12, 1998
(the "Annual Meeting"). At the Annual Meeting, the shareholders of the Company
voted to elect nine directors, John T. Casey, Merrick H. Reese, M.D.,
18
<PAGE> 19
Joseph S. Bailes, M.D., Nancy G. Brinker, Robert W. Daly, Boone Powell, Jr., J.
Taylor Crandall, Terrence J. Mulligan, and Burton S. Schwartz, M.D. for one-year
terms and until their successors are duly elected and qualified. The following
table sets forth the number of votes cast for and against/withheld with respect
to each of the nominees for director:
<TABLE>
<CAPTION>
Nominee For Against/Withheld
-------------------- ---------- ----------------
<S> <C> <C>
John T. Casey 38,260,152 55,127
Merrick H. Reese, M.D. 38,260,152 55,127
Joseph S. Bailes, M.D. 38,260,152 55,127
Nancy G. Brinker 38,260,152 55,127
Robert W. Daly 38,260,152 55,127
Boone Powell, Jr. 38,260,152 55,127
J. Taylor Crandall 38,260,152 55,127
Terrence J. Mulligan 38,260,152 55,127
Burton S. Schwartz, M.D. 38,260,152 55,127
</TABLE>
The shareholders of the Company also voted to amend the Employee Stock
Option Plan ("Plan") to increase the number of shares authorized to be issued
under the Plan from 3,272,402 to 5,000,000. The amendment was approved by the
shareholders with 35,119,406 votes cast for the amendment and 3,195,873 votes
cast against the amendment or withheld.
ITEM 6. EXHIBITS AND REPORTS ON FORM 8-K.
(a) Exhibits. See index to Exhibits following signatures.
(b) The Company filed no report on Form 8-K for the three months
ended June 30, 1998.
19
<PAGE> 20
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
PHYSICIAN RELIANCE NETWORK, INC.
Date: August 13, 1998 By: /s/ JOHN T. CASEY
-------------------------------
John T. Casey, Chairman and
Chief Executive Officer
By: /s/ MICHAEL N. MURDOCK
-------------------------------
Michael N. Murdock, Executive Vice President
and Chief Financial Officer
20
<PAGE> 21
INDEX TO EXHIBITS
<TABLE>
<CAPTION>
EXHIBIT
NUMBER DESCRIPTION
-------- ----------------------------------------------------------------
<S> <C> <C>
3.1 -- Articles of Incorporation of Registrant. (1)
3.2 -- Bylaws of the Registrant. (2)
4.1 -- See Exhibits 3.1 and 3.2 for provisions of the
Articles of Incorporation and Bylaws defining rights
of the holders of the Common Stock of the Registrant.
4.2 -- Form of Stock Certificate for the Common Stock of the
Registrant. (2)
4.3 -- Rights Agreement, dated as of June 2, 1997, between
Physician Reliance Network, Inc. and Harris Trust and
Savings Bank, as Rights Agent, which includes as
exhibits the Form of Rights Certificate and the
Summary of Rights Agreements. (3)
27.1 -- Financial Data Schedule, Six Months Ended June 30, 1998
27.2 -- Financial Data Schedule, Six Months Ended June 30, 1997
</TABLE>
(1) Incorporated by reference to the Registrant's Quarterly Report on
Form 10-Q for the quarter ended June 30, 1996.
(2) Incorporated by reference to the Registrant's Registration Statement
on Form S-1 (Registration No. 33-84436).
(3) Incorporated by reference to the Registrant's Current Report on Form
8-K, dated June 5, 1997.
<TABLE> <S> <C>
<ARTICLE> 5
<MULTIPLIER> 1,000
<S> <C>
<PERIOD-TYPE> 6-MOS
<FISCAL-YEAR-END> DEC-31-1998
<PERIOD-START> JAN-01-1997
<PERIOD-END> JUN-30-1998
<CASH> 4,378
<SECURITIES> 3,042
<RECEIVABLES> 146,321
<ALLOWANCES> 48,216
<INVENTORY> 12,200
<CURRENT-ASSETS> 138,914
<PP&E> 212,485
<DEPRECIATION> 56,328
<TOTAL-ASSETS> 431,890
<CURRENT-LIABILITIES> 53,890
<BONDS> 0
0
0
<COMMON> 510
<OTHER-SE> 318,456
<TOTAL-LIABILITY-AND-EQUITY> 431,980
<SALES> 171,867
<TOTAL-REVENUES> 187,807
<CGS> 154,805
<TOTAL-COSTS> 154,805
<OTHER-EXPENSES> 0
<LOSS-PROVISION> 7,989
<INTEREST-EXPENSE> 2,181
<INCOME-PRETAX> 22,832
<INCOME-TAX> 8,502
<INCOME-CONTINUING> 14,330
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> 14,330
<EPS-PRIMARY> 0.28
<EPS-DILUTED> 0.27
</TABLE>
<TABLE> <S> <C>
<ARTICLE> 5
<RESTATED>
<MULTIPLIER> 1,000
<S> <C>
<PERIOD-TYPE> 6-MOS
<FISCAL-YEAR-END> DEC-31-1997
<PERIOD-START> JAN-01-1997
<PERIOD-END> JUN-30-1997
<CASH> 651
<SECURITIES> 0
<RECEIVABLES> 133,491
<ALLOWANCES> 52,173
<INVENTORY> 6,185
<CURRENT-ASSETS> 119,475
<PP&E> 191,715
<DEPRECIATION> 37,719
<TOTAL-ASSETS> 382,606
<CURRENT-LIABILITIES> 42,567
<BONDS> 0
0
0
<COMMON> 483
<OTHER-SE> 279,279
<TOTAL-LIABILITY-AND-EQUITY> 382,606
<SALES> 134,465
<TOTAL-REVENUES> 145,487
<CGS> 125,164
<TOTAL-COSTS> 125,164
<OTHER-EXPENSES> 0
<LOSS-PROVISION> 44,483
<INTEREST-EXPENSE> 1,643
<INCOME-PRETAX> (25,803)
<INCOME-TAX> (8,518)
<INCOME-CONTINUING> (17,285)
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (17,285)
<EPS-PRIMARY> (0.34)
<EPS-DILUTED> (0.34)
</TABLE>
